Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol.

MLA

Müller, Christin, et al. “Comparison of Broad-Spectrum Antiviral Activities of the Synthetic Rocaglate CR-31-B (−) and the EIF4A-Inhibitor Silvestrol.” Antiviral Research, vol. 175, Mar. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.antiviral.2020.104706.

APA

Müller, C., Obermann, W., Schulte, F. W., Lange-Grünweller, K., Oestereich, L., Elgner, F., Glitscher, M., Hildt, E., Singh, K., Wendel, H.-G., Hartmann, R. K., Ziebuhr, J., & Grünweller, A. (2020). Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol. Antiviral Research, 175, N.PAG. https://doi.org/10.1016/j.antiviral.2020.104706

Chicago

Müller, Christin, Wiebke Obermann, Falk W. Schulte, Kerstin Lange-Grünweller, Lisa Oestereich, Fabian Elgner, Mirco Glitscher, et al. 2020. “Comparison of Broad-Spectrum Antiviral Activities of the Synthetic Rocaglate CR-31-B (−) and the EIF4A-Inhibitor Silvestrol.” Antiviral Research 175 (March): N.PAG. doi:10.1016/j.antiviral.2020.104706.